Jeffrey Friedland
Amministratore Delegato presso Friedland Global Capital Pte. Ltd.
Profilo
Jeffrey Friedland is the founder of Israel Plant Sciences Ltd.
(founded in 2015).
He is currently the Chief Executive Officer of Friedland Global Capital Pte.
Ltd.
(since 1979), the Chief Executive Officer of Global Corporate Strategies LLC (since 2011), and a Director at Cannrx Technology, Inc. (current position).
He has previously served as the Chief Executive Officer & Director of Kinder Holding Corp.
and Nexien BioPharma, Inc. He was also a Director at China GengSheng Minerals, Inc. from 2013 to 2014.
Additionally, he has worked as the Managing Director of Friedland Capital Equity Research LLC.
Mr. Friedland obtained his undergraduate degree from The University of Colorado.
Posizioni attive di Jeffrey Friedland
| Società | Posizione | Inizio |
|---|---|---|
| Friedland Global Capital Pte. Ltd. | Amministratore Delegato | - |
| Global Corporate Strategies LLC | Amministratore Delegato | 01/01/2011 |
Cannrx Technology, Inc.
 Cannrx Technology, Inc. Medical SpecialtiesHealth Technology CannRx Technology, Inc. is a private company that specializes in developing scientifically-based proprietary cannabis technologies. CannRx Technology, Inc. is based in New York, NY. The company's focus is on creating transformative technology that delivers more effective, higher bioavailability, scientifically formulated cannabis products. The company has developed patented, breakthrough technologies that will transform the cannabis industry. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Jeffrey Friedland
| Società | Posizione | Fine |
|---|---|---|
| NEXIEN BIOPHARMA, INC. | Amministratore Delegato | 07/03/2018 |
| CHINA GENGSHENG MINERALS, INC. | Direttore/Membro del Consiglio | 12/05/2014 |
Israel Plant Sciences Ltd.
 Israel Plant Sciences Ltd. Agricultural Commodities/MillingProcess Industries Israel Plant Sciences Ltd. is a holding Israeli company with subsidiaries that specialize in cannabis breeding, plant breeding support software development, and medicinal extraction from cannabis. The company is based in Herzliya, Israel. and has subsidiaries in Canada. The company was founded in 2015 by Jeffrey Friedland and Oded Sagee. | Fondatore | - |
Kinder Holding Corp.
 Kinder Holding Corp. Financial ConglomeratesFinance Kinder Holding Corp. engages in the research and development of cannabis cannabinoid-based drugs for various medical conditions and disorders. It focuses on identifying the appropriate compounds for its myotonic and muscular diseases drug candidate. The company was founded on November 10, 1952 and is headquartered in San Marino, CA. | Amministratore Delegato | - |
| Friedland Capital Equity Research LLC | Presidente | - |
Formazione di Jeffrey Friedland
| The University of Colorado | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CHINA GENGSHENG MINERALS, INC. | Non-Energy Minerals |
| NEXIEN BIOPHARMA, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
| Friedland Capital Equity Research LLC | Finance |
| Friedland Global Capital Pte. Ltd. | |
| Global Corporate Strategies LLC | |
Kinder Holding Corp.
Kinder Holding Corp. Financial ConglomeratesFinance Kinder Holding Corp. engages in the research and development of cannabis cannabinoid-based drugs for various medical conditions and disorders. It focuses on identifying the appropriate compounds for its myotonic and muscular diseases drug candidate. The company was founded on November 10, 1952 and is headquartered in San Marino, CA. | Finance |
Israel Plant Sciences Ltd.
Israel Plant Sciences Ltd. Agricultural Commodities/MillingProcess Industries Israel Plant Sciences Ltd. is a holding Israeli company with subsidiaries that specialize in cannabis breeding, plant breeding support software development, and medicinal extraction from cannabis. The company is based in Herzliya, Israel. and has subsidiaries in Canada. The company was founded in 2015 by Jeffrey Friedland and Oded Sagee. | Process Industries |
Cannrx Technology, Inc.
Cannrx Technology, Inc. Medical SpecialtiesHealth Technology CannRx Technology, Inc. is a private company that specializes in developing scientifically-based proprietary cannabis technologies. CannRx Technology, Inc. is based in New York, NY. The company's focus is on creating transformative technology that delivers more effective, higher bioavailability, scientifically formulated cannabis products. The company has developed patented, breakthrough technologies that will transform the cannabis industry. | Health Technology |
- Borsa valori
- Insiders
- Jeffrey Friedland
